#1 Clinical Trials Search in Europe

Nortriptyline

Nortriptyline, a tricyclic antidepressant, has been the subject of several clinical trials investigating its effectiveness in treating various medical conditions beyond depression. This article explores the use of nortriptyline in clinical trials for conditions such as gastroparesis, functional dyspepsia, Meniere’s disease, and more. We’ll examine the potential benefits, dosing regimens, and outcomes of these studies to better understand nortriptyline’s therapeutic applications.

Table of Contents

What is Nortriptyline?

Nortriptyline is a medication that belongs to a class of drugs called tricyclic antidepressants (TCAs). It is known by several brand names, including Pamelor, Allegron, and Norpress[1]. This medication has been used for many years to treat various conditions, primarily depression and certain types of chronic pain[2].

Uses of Nortriptyline

Nortriptyline is prescribed for several medical conditions:

  • Depression: It is commonly used to treat major depressive disorder, especially in older adults[3].
  • Chronic Pain: Nortriptyline has shown effectiveness in treating various types of chronic pain, including:
    • Neuropathic pain (pain caused by nerve damage)[2]
    • Sciatica (pain that radiates along the sciatic nerve)[2]
    • Functional dyspepsia (a type of stomach discomfort)[4]
  • Gastroparesis: This is a condition where the stomach takes too long to empty its contents. Nortriptyline is being studied as a potential treatment for this condition[5].
  • Headaches: It may be used to prevent certain types of headaches, including those associated with concussions[6].
  • Meniere’s Disease: This is an inner ear disorder that can cause vertigo (a spinning sensation), hearing loss, and ringing in the ears. Nortriptyline is being investigated as a potential treatment[7].

How Nortriptyline Works

Nortriptyline works by affecting certain chemicals in the brain called neurotransmitters. Specifically, it increases the levels of serotonin and norepinephrine, which are thought to play a role in mood regulation and pain perception[3]. This is why it can be effective for both depression and certain types of pain.

In the case of functional dyspepsia and gastroparesis, nortriptyline may work by affecting the nerves in the digestive system, helping to regulate stomach function and reduce discomfort[5].

Dosage and Administration

The dosage of nortriptyline can vary depending on the condition being treated and the individual patient. It’s typically started at a low dose and gradually increased over time. Here are some general guidelines based on the clinical trials:

  • For depression in older adults: Doses may range from 25 mg to 100 mg per day[3].
  • For functional dyspepsia: A common regimen is 10 mg daily for the first two weeks, then 25 mg daily for the next two weeks, followed by 50 mg daily for the remaining treatment period[4].
  • For post-concussive headaches in children: A dose of 10 mg daily may be used[6].

It’s important to note that these are just examples, and your doctor will determine the right dosage for you based on your specific condition and needs.

Side Effects

Like all medications, nortriptyline can cause side effects. Common side effects may include:

  • Dry mouth
  • Constipation
  • Blurred vision
  • Drowsiness
  • Dizziness
  • Weight gain

These side effects often improve as your body adjusts to the medication. However, if they persist or worsen, you should contact your healthcare provider[8].

Ongoing Research

Researchers continue to study nortriptyline for various conditions. Some areas of ongoing research include:

  • Its effectiveness in treating gastroparesis[5]
  • Its potential use in managing symptoms of Meniere’s disease[7]
  • Its role in treating functional dyspepsia[4]
  • Its effectiveness in managing post-concussive headaches in children[6]

These studies aim to better understand how nortriptyline works and identify new potential uses for this medication.

Condition Study Design Dosage Duration Primary Outcome
Idiopathic Gastroparesis Randomized, double-masked, placebo-controlled 10 mg to 75 mg, escalating 15 weeks Decrease in GCSI score
Nonulcer Dyspepsia Randomized, double-blind, placebo-controlled 25 mg nightly 8 weeks Adequate relief of abdominal pain/discomfort
Functional Dyspepsia Multi-center, double-blind, placebo-controlled 10 mg to 50 mg, escalating 12 weeks Symptom response (30% reduction from baseline)
Meniere’s Disease Randomized, double-blinded 7.5 mg + 10 mg topiramate, escalating 8 weeks Subjective improvement (MDOQ score)
Small Cell Carcinoma Phase 1, dose-escalation Escalating, combined with paclitaxel 28-day cycles Maximum tolerated dose

FAQ

  • What is nortriptyline and how does it work? Nortriptyline is a tricyclic antidepressant that works by increasing certain chemicals in the brain that help improve mood and reduce pain signals. In clinical trials, it's being studied for its potential to treat various conditions beyond depression.
  • What medical conditions are being studied with nortriptyline in clinical trials? Clinical trials are exploring nortriptyline's effectiveness in treating conditions such as gastroparesis, functional dyspepsia, non-ulcer dyspepsia, Meniere's disease, post-concussive headaches, and as a potential treatment for small cell carcinoma when combined with other medications.
  • How is nortriptyline typically administered in these trials? In most trials, nortriptyline is administered orally in capsule form. Dosages and schedules vary depending on the condition being studied, but often start at lower doses (e.g., 10 mg) and may be increased gradually over time.
  • Are there any common side effects of nortriptyline reported in these trials? While specific side effects weren't detailed in the provided trial information, tricyclic antidepressants like nortriptyline can cause side effects such as dry mouth, constipation, blurred vision, and drowsiness. In the trials, researchers monitored patients for side effects and adjusted dosages as needed.
  • How long do these clinical trials typically last? The duration of the trials varies widely depending on the condition being studied. Some trials last for a few weeks, while others extend for several months or even up to two years for long-term maintenance studies.

Ongoing Clinical Trials on Nortriptyline

  • Study on Dexamethasone for Patients with Moderate to Severe Depression: Evaluating Its Effectiveness with Mirtazapine, Citalopram, and Nortriptyline

    Recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Denmark

Glossary

  • Gastroparesis: A digestive disorder that slows or stops the movement of food from the stomach to the small intestine, often causing nausea, vomiting, and abdominal pain.
  • Functional Dyspepsia: A common digestive condition characterized by recurring pain or discomfort in the upper abdomen, often accompanied by bloating, early satiety, or nausea.
  • Meniere's Disease: A disorder of the inner ear that can cause vertigo, fluctuating hearing loss, tinnitus (ringing in the ears), and a feeling of fullness in the ear.
  • GCSI: Gastroparesis Cardinal Symptom Index, a tool used to measure the severity of gastroparesis symptoms.
  • Placebo: A substance with no active therapeutic effect, used as a control in clinical trials to test the effectiveness of a drug.
  • Double-blind: A type of clinical trial where neither the participants nor the researchers know who is receiving the actual treatment and who is receiving a placebo.
  • Quality of Life (QoL): A measure of an individual's overall well-being, including physical, mental, and social aspects of their life.
  • Tricyclic Antidepressant (TCA): A class of medications primarily used to treat depression, but also used for other conditions such as chronic pain and anxiety disorders.
  • Idiopathic: A term used to describe a condition or disease with no known cause.
  • Nonerosive Reflux Disease (NERD): A type of gastroesophageal reflux disease (GERD) where patients experience typical reflux symptoms but do not have visible damage to the esophagus lining when examined.

References

  1. https://clinicaltrials.gov/study/NCT02881125
  2. https://clinicaltrials.gov/study/NCT00009672
  3. https://clinicaltrials.gov/study/NCT00000378
  4. https://clinicaltrials.gov/study/NCT03652571
  5. https://clinicaltrials.gov/study/NCT00765895
  6. https://clinicaltrials.gov/study/NCT04226365
  7. https://clinicaltrials.gov/study/NCT05582837
  8. https://clinicaltrials.gov/study/NCT00547703